多发性骨髓瘤 CAR-NK 细胞治疗的最新进展:细胞来源与靶抗原的综合综述 State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. PubMed 2025/11/20 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:CAR-T技术:CAR-NK技术:NK 细胞
多发性骨髓瘤的新型免疫靶点:生物学意义与治疗潜力 Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential. PubMed 2025/07/01 发表Biomark ResQ1 · IF 14.6(JCR 2025) 靶点:CD38靶点:CD70靶点:BCMA技术:双特异性抗体多发性骨髓瘤地区:欧洲
多发性骨髓瘤 CAR 治疗的靶点 Targets for CAR Therapy in Multiple Myeloma. PubMed 2025/06/24 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD19靶点:CD38靶点:CD70多发性骨髓瘤地区:其他